Market Newsdesk

Cross Country Healthcare to be Acquired by Knox Lane in All-Cash Transaction Valued at $437 Million

BOCA RATON, Fla. & SAN FRANCISCO–(BUSINESS WIRE)–
Cross Country Healthcare, Inc. (NASDAQ: CCRN) (“Cross Country Healthcare” or the “Company”) a leading, technology-driven healthcare workforce solutions company, today announced that it has entered into a definitive agreement to be acquired by Knox Lane, a growth-oriented investment firm. Under the terms of the agreement, Knox Lane will acquire all outstanding shares of Cross Country Healthcare common stock for $13.25 per share in an all-cash transaction valued at $437 million. The transaction represents a premium of approximately 31 percent to Cross Country Healthcare’s closing price on May 6, 2026, and a 45 percent premium to the Company’s volume-weighted average trading price for the 90-day period ended May 6, 2026.

Upon completion of the transaction, Cross Country Healthcare will become a privately held platform company in Knox Lane’s portfolio and will cease trading on Nasdaq stock exchange.

“We are excited to be working with Knox Lane, who brings significant and direct expertise in our sector to help Cross Country Healthcare enter its next phase of growth, while delivering significant and immediate value to our stockholders,” said Kevin Clark, Co-Founder, Chairman and Chief Executive Officer of Cross Country Healthcare. “Knox Lane truly appreciates our iconic brand and the strength of our platform, especially the proprietary technology we’ve built on four decades of real‑world experience. That foundation uniquely positions organizations to design, predict, and optimize labor strategies with market‑leading precision. Just as important, Knox Lane recognizes the exceptional team behind it all, delivering best‑in‑class solutions to our clients and the thousands of professionals we proudly support every day,” he continued.

“Cross Country Healthcare is a longstanding leader and innovator in healthcare workforce solutions, with an unparalleled focus on delivering clinical excellence,” said John Bailey, Managing Partner at Knox Lane and Shamik Patel, Partner at Knox Lane. “We are excited to leverage our extensive experience to bring added strategic focus and capabilities to the business to build on its already strong foundation, technology, and customer relationships.”

Transaction Details

The proposed transaction is expected to close in the third quarter of 2026, subject to customary closing conditions, including approval by Cross Country Healthcare stockholders and required regulatory approvals.

Upon completion of the transaction, the Company will continue to operate under the Cross Country Healthcare name and brand.

Additional details regarding the transaction will be included in a Current Report on Form 8-K to be filed by Cross Country Healthcare with the U.S. Securities and Exchange Commission (“SEC”).

Advisors

BofA Securities, Inc. is serving as exclusive financial advisor to Cross Country Healthcare and Davis Polk & Wardwell LLP is serving as legal counsel. MTS Health Partners is serving as exclusive financial advisor to Knox Lane and Kirkland & Ellis LLP is serving as its legal counsel.

About Cross Country Healthcare, Inc.

Cross Country Healthcare, Inc. (Nasdaq: CCRN) is a technology-driven healthcare workforce solutions company, delivering an AI-powered digital platform and advisory services backed by 40 years of healthcare labor expertise to help health systems optimize and sustain their entire labor ecosystem.

Through Intellify®, its cloud-based workforce and vendor management platform designed to integrate with core hospital systems, Cross Country helps improve transparency across the labor ecosystem. Intellify® unifies workforce management across service lines, including non-clinical, nursing, allied health, and locums, into a single, centralized view of internal and contingent labor. Powered by real-time analytics and AI-driven insights, the platform helps leaders forecast demand, optimize labor utilization, streamline workflows, and improve cost efficiency while supporting high-quality care delivery.

About Knox Lane

Based in San Francisco, Knox Lane is a growth-oriented investment firm comprised of a team of accomplished investors and operators with a shared work history and a strong track record of partnering with leading companies to accelerate transformational growth. Knox Lane employs an investor-operator mindset and seeks to provide support across a number of business components, including human capital, brand management, AI & end-to-end digital transformation, sourcing, supply chain and logistics, strategic acquisitions and business development. For more information, please visit www.knoxlane.com.

Important Information and Where to Find It

This communication relates to the proposed transaction (the “Merger”) between the Company and Knox Lane, as contemplated by that certain Agreement and Plan of Merger (the “Merger Agreement”), dated as of May 6, 2026, by and among the Company, KL Criss Cross Intermediate, LLC (“Parent”), and KL Criss Cross Merger Sub, Inc., a wholly owned subsidiary of Parent (“Merger Sub”). In connection with this proposed Merger, the Company will file a definitive proxy statement on Schedule 14A (the “proxy statement”) or other documents with the SEC. This communication is not a substitute for any proxy statement or other document the Company may file with the SEC in connection with the proposed transaction. INVESTORS AND SECURITY HOLDERS OF THE COMPANY ARE URGED TO READ THE PROXY STATEMENT, INCLUDING THE DOCUMENTS INCORPORATED BY REFERENCE INTO THE PROXY STATEMENT, AND OTHER DOCUMENTS THAT MAY BE FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. The proxy statement and/or a notice of internet availability of proxy materials, when available, will be mailed to the Company’s stockholders of record as of the close of business on the record date for the Company’s stockholders meeting, as applicable. Investors and security holders will be able to obtain free copies of these documents, when available, and other documents filed with the SEC by the Company through the website maintained by the SEC at http://www.sec.gov. Copies of the documents filed with the SEC by the Company will be available free of charge on the Company’s internet website at https://ir.crosscountryhealthcare.com/ or by contacting the Company’s primary investor relations contact by email at [email protected] or by phone at 561-237-8310.

Participants in the Solicitation

The Company, Parent, Merger Sub, their respective directors, and certain of their respective executive officers may be considered participants in the solicitation of proxies in connection with the proposed Merger. Information about the directors and executive officers of the Company, their ownership of shares of the Company’s common stock, and the Company’s transactions with related persons is set forth in its Annual Report on Form 10-K for the fiscal year ended December 31, 2025, which was filed with the SEC on March 10, 2026, in its definitive proxy statement on Schedule 14A for its 2026 Annual Meeting of Stockholders in the sections entitled “Security Ownership of Certain Beneficial Owners and Management” and “Related Party Transactions”, which was filed with the SEC on March 30, 2026, as amended by Amendment No. 1 thereto filed on April 2, 2026, certain of its Quarterly Reports on Form 10-Q, and certain of its Current Reports on Form 8-K.

These documents can be obtained free of charge from the sources indicated above. Additional information regarding the participants in the proxy solicitations and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in the proxy statement and other relevant materials to be filed with the SEC when they become available.

No Offer or Solicitation

This communication is for informational purposes only and is not intended to and shall not constitute an offer to buy or sell or the solicitation of an offer to buy or sell any securities, or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

Forward Looking Statements

This communication contains “forward-looking statements” within the Private Securities Litigation Reform Act of 1995. Any statements contained in this communication that are not statements of historical fact, including statements regarding the proposed Merger, including the expected timing and closing of the proposed Merger; the Company’s ability to consummate the proposed Merger; the expected benefits of the proposed Merger and other considerations taken into account by the Company’s Board of Directors in approving the proposed Merger; the amounts to be received by stockholders; and expectations for the Company prior to and following the closing of the proposed Merger, may be deemed to be forward-looking statements. All such forward-looking statements are intended to provide management’s current expectations for the future of the Company based on current expectations and assumptions relating to the Company’s business, the economy and other future conditions. Forward-looking statements generally can be identified through the use of words such as “believes,” “anticipates,” “may,” “should,” “will,” “plans,” “projects,” “expects,” “expectations,” “estimates,” “forecasts,” “predicts,” “targets,” “prospects,” “strategy,” “signs,” and other words of similar meaning in connection with the discussion of future performance, plans, actions or events. Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties, and changes in circumstances that are difficult to predict. Such risks and uncertainties include, among others: (i) the timing to consummate the proposed Merger, (ii) the risk that a condition of closing of the proposed Merger may not be satisfied or that the closing of the proposed Merger might otherwise not occur, (iii) the risk that a regulatory approval that may be required for the proposed Merger is not obtained or is obtained subject to conditions that are not anticipated, (iv) the diversion of management time on transaction-related issues, (v) risks related to disruption of management time from ongoing business operations due to the proposed Merger, (vi) the risk that any announcements relating to the proposed Merger could have adverse effects on the market price of the Company’s common stock, (vii) the risk that the proposed Merger and its announcement could have an adverse effect on the ability of the Company to retain customers and retain and hire key personnel and maintain relationships with its suppliers and customers, (viii) the occurrence of any event, change, or other circumstance or condition that could give rise to the termination of the Merger Agreement, including in circumstances requiring the Company to pay a termination fee, (ix) the risk that competing offers will be made, (x) unexpected costs, charges or expenses resulting from the Merger, (xi) potential litigation relating to the Merger that could be instituted against the parties to the Merger Agreement or their respective directors, managers, or officers, including the effects of any outcomes related thereto, (xii) worldwide economic or political changes that affect the markets that the Company’s businesses serve which could have an effect on demand for the Company’s services and impact the Company’s profitability, (xiii) effects from global pandemics, epidemics, or other public health crises, (xiv) changes in marketplace conditions, such as alternative modes of healthcare delivery, reimbursement, and customer needs, and (xv) disruptions in the global credit and financial markets, including diminished liquidity and credit availability, changes in international trade agreements, including tariffs and trade restrictions, cyber-security vulnerabilities, foreign currency volatility, swings in consumer confidence and spending, costs of providing services, retention of key employees, and outcomes of legal proceedings, claims and investigations. Accordingly, actual results may differ materially from those contemplated by these forward-looking statements. Investors, therefore, are cautioned against relying on any of these forward-looking statements. They are neither statements of historical fact nor guarantees or assurances of future performance. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in the Company’s filings with the SEC, including the risks and uncertainties identified in Part I, Item 1A – Risk Factors of the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 and in the Company’s other filings with the SEC. The list of factors is not intended to be exhaustive.

These forward-looking statements speak only as of the date of this communication, and, except as may be required by applicable law, the Company does not assume any obligation to update or revise any forward-looking statement made in this communication or that may from time to time be made by or on behalf of the Company.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260506144806/en/

Cross Country Healthcare

Investors

Josh Vogel,

Vice President, Investor Relations

[email protected]

561-237-8310

Media

Jim Golden / Clayton Erwin

Collected Strategies

[email protected]

212-379-2072

Knox Lane

Woomi Yun / Erik Carlson

Joele Frank, Wilkinson Brimmer Katcher

212-355-4449

KEYWORDS: California Florida United States North America

INDUSTRY KEYWORDS: Technology Finance Health Technology Professional Services Business Practice Management Other Health General Health Health Artificial Intelligence

MEDIA:

Logo

Restructuring is expected to reinforce return-driven spending initiative, reshore select operational functions, and enable a leaner team to leverage agentic AI tooling to reduce costs and accelerate execution.

Grupo Supervielle Reports 1Q26 Results

Attributable net loss narrowed sequentially, while CET1 remained strong at 15.4%

Excluding extraordinary severance charges, net income was AR$6.7 billion

Operating trends improved supported by lower cost of risk, funding optimization and continued efficiency gains

BUENOS AIRES, Argentina–(BUSINESS WIRE)–Grupo Supervielle S.A. (NYSE: SUPV; BYMA: SUPV), (“Supervielle” or the “Company”) a universal financial services group headquartered in Argentina with a nationwide presence, today reported results for the three-month period ended March 31, 2026.

Starting 1Q20, the Company began reporting results applying Hyperinflation Accounting, in accordance with IFRS rule IAS 29 (“IAS 29”) as established by the Central Bank.

Commenting on first quarter 2026 results, Patricio Supervielle, Grupo Supervielle’s Chairman & CEO, noted:“The first quarter marked an early but important step in our earnings recovery, supported by improving asset quality trends and continued progress in aligning our operating model with evolving client behavior. During the quarter, we implemented a headcount rightsizing plan reflecting the structural shift toward a more efficient distribution model, with a growing share of customer activity migrating to digital and virtual hub service channels. Excluding the related extraordinary severance charges, we delivered net income of AR$6.7 billion, or approximately 2.5% adjusted ROAE. Our capital ratio remained solid at 15.4%, in line with December 31, 2025, while we reported a AR$17.1 billion net loss in the quarter.

We maintained a disciplined approach to balance sheet deployment, prioritizing profitability and asset quality, with a continued focus on risk-adjusted growth. Asset quality showed encouraging signs of stabilization, with delinquency trends improving through March and net cost of risk easing to 6% from the 10% reported in the prior quarter, supported by collection and refinancing initiatives implemented since December 2025, reinforcing our view that the peak in cost of risk was reached in the fourth quarter of 2025. In this context, loans declined 5.6% sequentially, reflecting subdued credit demand in local currency alongside our disciplined and selective origination approach, with a clear focus on profitable growth. On the funding side, deposits decreased 4.7% quarter-on-quarter, primarily driven by a deliberate reduction in higher-cost wholesale peso funding, as we continued to improve the quality and stability of our deposit base. In turn, both U.S. loans and deposits continued to increase in original currency terms. Net interest margin stood at 17.7% for the quarter, well above the levels observed during the peak of monetary tightening in 3Q25, supported by a more stable rate environment, with interest rates declining in March.

Importantly, March represented a clear inflection point, as underlying monthly earnings turned positive before the impact of the retirement plan, reaching AR$16.6 billion, supported by more stable interest rate conditions, improving financial risk dynamics and continued moderation in credit charges. This trend has extended into April, with margins and asset quality showing early signs of stabilization. While the NPL ratio stood at 5.6% at quarter-end, compared to 5.0% in December, it improved sequentially in March versus February, reflecting an early inflection in asset quality trends. At the same time, the plan positions us for a structurally leaner cost base going forward.

From a macro perspective, the operating environment remained challenging in the first quarter, with higher inflation and still-tight monetary conditions, but the backdrop became more stable toward the end of the period. Greater visibility on interest rates, and continued policy progress are beginning to support a more predictable environment for funding costs, margins and, over time, a recovery in credit demand.

During the quarter, we continued to advance our ecosystem strategy, deepening integration between the Bank and IOL and scaling cross-selling initiatives. The launch of ‘Cuenta Hit IOL’ at the Bank, supported strong client acquisition momentum, with a peak of 13,000 new accounts in March. IOL continued to expand its platform, with assets under custody reaching US$2.7 billion, while also enhancing its value proposition through innovation, including the recent launch of new artificial intelligence capabilities that allow clients to connect their preferred AI platform to their accounts, allowing them to interact, analyze and manage their investments in a more intuitive and integrated way. These initiatives reflect our focus on building a more agile, client-centric and scalable platform.

Looking ahead, we remain constructive on the remainder of 2026. The quarter confirmed that underlying profitability is recovering, that credit costs are moving off their peak, and that our strategic actions are beginning to translate into a more efficient and resilient earnings profile. At the same time, the recent staff-level agreement with the IMF provides additional external validation that reform momentum is strengthening, with continued progress on fiscal discipline, key legislation and the monetary framework, supporting a more stable and predictable macro environment. With a strong capital base, a structurally improving cost trajectory, disciplined risk management and a clear focus on profitable growth, Grupo Supervielle is well positioned to strengthen returns as Argentina’s financial system continues to normalize,” concluded Mr. Supervielle.

First quarter 2026 Highlights

PROFITABILITY

The Company reported an Attributable Net Loss of AR$17.1 billion in 1Q26 compared to a Net Loss of AR$21.4 billion in 4Q25 and a net gain of AR$ 10.5 billion in 1Q25. During the quarter, the Company implemented a headcount rightsizing plan at its Banking business ecosystem to align with its shift toward a more efficient distribution model, with a growing share of customer activity migrating to digital and virtual hub service channels. The plan included as of March 31, 2026, 9% of the headcount. Excluding the related extraordinary severance charges, the Company posted Adjusted Net Income of AR$6.7 billion.

Operating conditions during 1Q26 evolved gradually, following two periods of heightened financial volatility. January and February saw lower but still volatile interest rates, which constrained credit demand and financial intermediation. Conditions improved toward the end of the quarter, particularly in March, as greater visibility on the monetary policy framework contributed to a more stable interest rate environment, easing funding costs and supporting stabilization. In this context, quarterly profitability reflected the normalization of financial income following the strong performance in 4Q25, when market‑related results benefited from the recovery in investment portfolio valuations after election‑related volatility. Net financial margins declined sequentially but remained broadly in line with levels observed earlier in 2025 and well above those recorded during the peak of monetary tightening in 3Q25. Operating expenses increased sequentially, primarily reflecting extraordinary personnel costs associated with the implementation of the headcount rightsizing plan.

Loan loss provisions declined significantly from the previous quarter, reflecting easing delinquency trends through January, February and March and the early impact of portfolio management, collections and refinancing initiatives undertaken since late 2025, together with a disciplined and cautious origination strategy. While asset quality indicators remained above December levels, their trajectory during the quarter suggested an early inflection in portfolio performance. On a year‑on‑year (”YoY”) basis, provisioning levels continued to reflect a challenging macroeconomic environment and the increase in delinquency levels across industry.

Overall, first quarter results reflect a transitional period, with underlying earnings trends improving toward the end of the quarter amid greater macro‑financial stability, early signs of asset quality stabilization and continued progress on efficiency initiatives. This was partially offset by extraordinary restructuring costs. 1Q26 ROAE was -6.2% while adjusted ROAE was 2.4%. ROAA was -0.8%.

In 1Q26, the Company reported a Loss before income tax of AR$22.4 billion, compared to losses before income tax of AR$40.7 billion in 4Q25 and AR$95.9 billion in 3Q25. This loss includes AR$36.6 billion in extraordinary personnel expenses associated with the headcount rightsizing plan. Excluding the extraordinary severance cost, Profit before income tax was AR$ 14.2 billion.

During 1Q26, the Net Financial Margin totaled AR$254.7 billion in 1Q26, declining 5.3% QoQ while increasing 9.5% YoY. The sequential performance reflects margin normalization following two highly volatile quarters. Both 3Q25 and 4Q25 were marked by elevated market volatility, with 4Q25 representing a particularly high comparison base, as investment portfolio yields recovered the losses recorded in 3Q25 after election‑related volatility subsided. Lower interest rates in 1Q26 helped stabilize the net financial margin at levels comparable to 1Q25 and 2Q25. During the quarter, yields on government securities and loan accrual rates declined in line with the prevailing interest rate environment, and funding costs eased, reversing from prior volatility. January and February were characterized by volatile interest rates that weighed on credit demand, while March benefited from improved liquidity and market conditions, supporting margins toward quarter-end. Client Net Financial Income increased 2.5% QoQ and was broadly stable YoY, supported by lower funding costs despite weaker credit demand and a more gradual pace of loan repricing. Market‑related Net Financial Income declined 17.5% QoQ due to lower investment portfolio yields versus the unusually high levels in 4Q25 but remained 31.3% higher YoY.

Net Interest Margin (NIM) was 17.7% in 1Q26, declining 100 bps QoQ and 150 bps YoY, but well above the levels observed during the peak of monetary tightening in 3Q25. AR$ NIM was at 20.7% in 1Q26, declining 66 bps QoQ and 14 bps YoY. The sequential contraction primarily reflects lower peso investment portfolio gains following an unusually strong performance in 4Q25, which benefited from the recovery in the valuation of peso‑denominated securities after the heightened volatility observed in 3Q25. This was partially mitigated by improvements in funding costs, mainly in March. Total NIM was affected by lower yields from U.S. dollar‑denominated portfolios when converted to pesos, reflecting exchange rate appreciation during the quarter.

YoY, the decline in NIM reflects narrower loan spreads driven by a lower share of retail lending, together with a higher proportion of dollar‑denominated positions on the balance sheet.

The total NPL ratio was 5.6% at the end of 1Q26, up from 5.0% in December 2025, reflecting the carry‑over of credit stress from prior quarters in a challenging macroeconomic environment. Delinquency indicators decelerated in February and eased slightly in March, suggesting an early inflection point in portfolio performance. This sequential improvement reflects better collection and refinancing dynamics driven by active portfolio management and a disciplined origination strategy, particularly in the retail segment since early 2025.

Loan loss provisions (LLPs) declined 43.0% QoQ to AR$67.6 billion in 1Q26. This reduction in LLPs is consistent with easing delinquency trends throughout the quarter and reflects early benefits from collection and refinancing initiatives implemented since December 2025, together with disciplined risk-adjusted loan origination. LLPs peaked in 4Q25, when cumulative credit stress and a less supportive macroeconomic backdrop, along with updates to macroeconomic assumptions under the ECL framework, drove elevated charges.

The Coverage Ratio was 103.9% as of March 31, 2026, compared to 111.6% as of December 31, 2025, and 152.7% as of March 31, 2025.

Efficiency ratio was 68.9% in 1Q26, reflecting the impact of extraordinary personnel expenses related to the implementation of a voluntary retirement and headcount rightsizing plan, along with lower revenues versus the prior quarter. Personnel expenses included AR$36.6 billion in extraordinary severance and early retirement costs. Excluding these items, personnel expenses would have declined approximately 11% QoQ and Efficiency ratio would have been 55.8%, underscoring continued cost discipline and structural efficiency gains. These effects were partially offset by a 18.3% QoQ reduction in administrative expenses as commercial and advertising normalized after elevated levels in 4Q25.

The Loans to Deposits Ratio was 77.1% as of March 31, 2026, compared to 77.8% as of December 31, 2025, and 66.5% as of March 31, 2025.

Total Deposits were AR$5,340.4 billion at quarter-end, decreasing 4.7% QoQ and increasing 8.6% YoY. The sequential decline was driven by deliberate deleveraging of peso‑denominated institutional funding, seasonal declines in checking account balances and the negative translation effect from peso appreciation on U.S. dollar deposits. U.S. dollar deposits increased 6.1% in dollar term, but declined 8.1% when translated to pesos due to the peso appreciation during the period. Total private sector deposits were AR$4,993.9 billion, declining 8.5% QoQ and increasing 5.3% YoY in real terms. AR$ deposits totaled AR$3,617.0 billion, decreasing 2.9% QoQ and 3.4% YoY in real terms.

Foreign currency deposits amounted to US$1.2 billion, increasing 6.1% QoQ and 51.0% YoY.

Total Assets were AR$8,154.8 billion as of March 31, 2026, decreasing 4.4% QoQ and increasing 14.6% YoY. The sequential decline mainly reflected balance sheet deleveraging, lower liquidity requirements following the late-2025 easing of reserve requirements -although reserve levels remained elevated- and the translation impact of peso appreciation on U.S.-dollar assets.

The leverage ratio (Assets to Shareholders’ Equity) was 7.5x, down 20 bps QoQ, from 7.7x as of December 31, 2025, and increased 150 bps YoY, from 6.0x as of March 31, 2025.

Total Loans amounted to AR$4,115.1 billion as of March 31, 2026, decreasing 5.6% QoQ but increasing 25.8% YoY and 156.9% since March 31, 2024. Loans growth since March 31, 2024 has significantly outpaced the industry’s 130% increase, and YoY growth exceeded the industry’s 18.0% gain.

The sequential decline was primarily driven by a 6.4% reduction in peso‑denominated loans, reflecting seasonality and prudent credit origination policies. In addition, the peso appreciation during the quarter negatively impacted the AR$ value of U.S.- dollar loans. While U.S.- dollar loans increased 12.8% when in dollar terms, they declined 2.4% in peso terms due to FX translation.

Common Equity Tier 1 Ratio (CET1) stood at 15.4% as of March 31, 2026, unchanged from the prior quarter and 10 basis points higher than a year earlier.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260506983731/en/

[email protected]

KEYWORDS: New York Latin America North America United States South America Argentina

INDUSTRY KEYWORDS: Banking Asset Management Professional Services Finance

MEDIA:

Logo

Almonty Industries Inc. Appoints Jorge Beristain as Chief Financial Officer to Lead Next Phase of Growth

TORONTO–(BUSINESS WIRE)–
Almonty Industries Inc. (“Almonty” or the “Company”) (Nasdaq: ALM) (TSX: AII) (ASX: AII) (Frankfurt: ALI1), a leading global producer of tungsten critical to U.S. defense and advanced technology industries, today announced the appointment of Jorge Beristain, CFA, as Chief Financial Officer, effective June 1, 2026. Mr. Beristain’s appointment positions Almonty for its next phase of growth as the Company scales its flagship Sangdong Mine in South Korea and continues to expand its strategic role in the Western tungsten supply chain in the United States, Portugal and Spain. Brian Fox has departed from his role as Chief Financial Officer, effective immediately, and the Company thanks him for his service. Until Mr. Beristain’s start date, Guillaume de Lamaziere, the Company’s Chief Development Officer, will serve as Interim Chief Financial Officer.

Mr. Beristain is a strategic, dynamic finance executive with a proven track record of building, funding, growing, and creating value at publicly traded basic materials and mining companies. He most recently served as Vice President, Finance of Ryerson Holding Corp (“Ryerson”) (NYSE: RYI), a US$5 billion revenue NYSE-listed metals service center, where he was a key advisor to the CEO, CFO and the Board, and helped double the company’s market capitalization. He previously served as Chief Financial Officer of Central Steel & Wire Co., a US$800 million Ryerson subsidiary and currently serves as an Independent Director of Elevra Lithium Limited (NASDAQ/ASX: ELVR). Earlier in his career, Mr. Beristain was a top-three-ranked Wall Street equity research analyst, serving as Managing Director and Head of Americas Metals & Mining Equity Research at Deutsche Bank Securities. He holds a Bachelor of Commerce from the University of Alberta and has held the CFA designation for more than 25 years. His combination of operating experience, public-company executive leadership, board service, and Wall Street capital markets fluency makes him uniquely suited to lead Almonty’s finance organization as the Company executes on its global growth strategy and enters into its next phase.

Mr. de Lamaziere will serve as Interim Chief Financial Officer until Mr. Beristain’s start date. He currently serves as the Company’s Chief Development Officer and brings over three decades of senior financial leadership experience across international and U.S. regulated financial markets, including former roles as Chief Executive Officer and Chief Operating & Financial Officer of AIG Asset Management (Europe) Ltd., Chief Operating & Financial Officer of Banque AIG in Paris, and senior finance positions at Goldman Sachs in New York and Paris. He is a CFA Charterholder, Certified Public Accountant, Professional Risk Manager, Chartered Wealth Manager, and Chartered Global Management Accountant.

Management Commentary

Lewis Black, Chairman, President and Chief Executive Officer of Almonty, said: “Jorge is exactly the right leader for the next phase of Almonty’s growth as our Sangdong Mine comes on line with revenue generation this year. His track record, public-company experience and decades of Wall Street capital markets fluency in basic materials and mining are extraordinary, and rarely found in a single executive. As we ramp our flagship Sangdong Mine in South Korea and execute on our broader strategic priorities, Jorge’s finance acumen, investor-relations expertise, and value-creation track record will be instrumental in delivering for our shareholders, customers, and the Western allies who depend on a secure tungsten supply chain. We thank Brian for his service to the Company and wish him well. We are also grateful to Guillaume for stepping in as Interim Chief Financial Officer to ensure continuity until Jorge joins Almonty.”

About Almonty

Almonty (Nasdaq: ALM) (TSX: AII) (ASX: AII) (Frankfurt: ALI1) is a leading supplier of conflict-free tungsten – a strategic metal critical to the defense and advanced technology sectors. As geopolitical tensions heighten, tungsten has become essential for armor, munitions, and electronics manufacturing. Almonty’s flagship Sangdong Mine in South Korea, historically one of the world’s largest and highest-grade tungsten deposits, is expected to be a major contributor to the global non-China tungsten supply chain upon reaching full capacity, directly addressing critical supply vulnerabilities highlighted by recent U.S. defense procurement bans and export restrictions by China. With established operations in Portugal and additional projects in the U.S. and Spain, Almonty is strategically aligned to meet rapidly rising demand from Western allies committed to supply-chain security and defense readiness. To learn more, please visit https://almonty.com.

Legal Notice

The release, publication, or distribution of this announcement in certain jurisdictions may be restricted by law and therefore persons in such jurisdictions into which this announcement is released, published, or distributed should inform themselves about and observe such restrictions.

Cautionary Note Regarding Forward-Looking Information

This news release contains “forward-looking statements” and “forward-looking information” within the meaning of applicable securities laws. All statements, other than statements of present or historical facts, are forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and assumptions and accordingly, actual results could differ materially from those expressed or implied in such statements. You are hence cautioned not to place undue reliance on forward-looking statements. Forward-looking statements are typically identified by words such as “plan”, “development”, “growth”, “continued”, “intentions”, “expectations”, “emerging”, “evolving”, “strategy”, “opportunities”, “anticipated”, “trends”, “potential”, “outlook”, “ability”, “additional”, “on track”, “prospects”, “viability”, “estimated”, “reaches”, “enhancing”, “strengthen”, “target”, “believes”, “next steps” or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved.

Forward-looking statements in this news release include, but are not limited to, statements concerning the appointment of Mr. de Lamaziere as Interim Chief Financial Officer, the appointment of Mr. Beristain as Chief Financial Officer effective June 1, 2026 and the expected contribution of these appointments to the next phase of the Company’s growth. Forward-looking statements are based upon certain assumptions and other important factors that, if untrue, could cause actual results to be materially different from future results expressed or implied by such statements. There can be no assurance that forward-looking statements will prove to be accurate.

Forward-looking statements are also subject to risks and uncertainties facing the Company’s business, including, without limitation, the appointment of Mr. de Lamaziere as Interim Chief Financial Officer, the appointment of Mr. Beristain as Chief Financial Officer effective June 1, 2026 and the expected contribution of these appointments to the next phase of the Company’s growth as well as the risks identified in the Company’s annual information form for the year ended December 31, 2025 dated March 18, 2026. Although Almonty has attempted to identify important factors that could cause actual results, level of activity, performance or achievements to differ materially from those contained in forward-looking statements, there may be other factors that could cause results, level of activity, performance or achievements not to be as anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, and even if events or results described in the forward-looking statements are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on, Almonty. Accordingly, readers should not place undue reliance on forward-looking statements and are cautioned that actual outcomes may vary.

Investors are cautioned against attributing undue certainty to forward-looking statements. Almonty cautions that the foregoing list of material factors is not exhaustive. When relying on Almonty’s forward-looking statements and information to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. Almonty has also assumed that material factors will not cause any forward-looking statements and information to differ materially from actual results or events. However, the list of these factors is not exhaustive and is subject to change and there can be no assurance that such assumptions will reflect the actual outcome of such items or factors.

THE FORWARD-LOOKING INFORMATION CONTAINED IN THIS NEWS RELEASE REPRESENTS THE EXPECTATIONS OF ALMONTY AS OF THE DATE OF THIS NEWS RELEASE AND, ACCORDINGLY, IS SUBJECT TO CHANGE AFTER SUCH DATE. READERS SHOULD NOT PLACE UNDUE IMPORTANCE ON FORWARD-LOOKING INFORMATION AND SHOULD NOT RELY UPON THIS INFORMATION AS OF ANY OTHER DATE. WHILE ALMONTY MAY ELECT TO, IT DOES NOT UNDERTAKE TO UPDATE THIS INFORMATION AT ANY PARTICULAR TIME, WHETHER AS A RESULT OF NEW INFORMATION, FUTURE EVENTS OR OTHERWISE, EXCEPT AS REQUIRED IN ACCORDANCE WITH APPLICABLE LAWS.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260506216393/en/

Company

Lewis Black

Chairman, President & CEO

(647) 438-9766

[email protected]

Investor Relations

Lucas A. Zimmerman

Managing Director MZ Group – MZ North America

(949) 259-4987

[email protected]

www.mzgroup.us

KEYWORDS: North America Canada

INDUSTRY KEYWORDS: Natural Resources Defense Mining/Minerals Other Defense

MEDIA:

Logo

Essential Utilities Reports Q1 2026 Results

Affirms Financial and Growth Guidance

• GAAP Earnings of $0.79 per share for Q1 2026 and adjusted earnings per share of $0.83 (non-GAAP); Q1 2026 non-GAAP results exclude $0.04 of transaction costs associated with the pending merger with American Water
• Affirms anticipated growth in earnings per share at a compound annual growth rate of 5 to 7%
• Invested $269 million in infrastructure in the first three months of the year; on track to invest $1.7 billion in 2026
• Received order from Kentucky Public Service Commission approving merger with American Water
• Closed on $18 million purchase of the Greenville Municipal Water Authority in Mercer County, PA

BRYN MAWR, Pa.–(BUSINESS WIRE)–
Essential Utilities Inc. (NYSE: WTRG) today reported results for the first quarter ended March 31, 2026.

Company Highlights

“Through continued strong operating performance, a focus on cost control, and making investments designed to improve customer experience, we expect another strong year in 2026. While our team is preparing for our merger with American Water, expected to close in the first quarter of 2027, our primary focus remains on operating the company with excellence,” said Essential Utilities Chairman and Chief Executive Officer Christopher Franklin. “We are excited by the combination of American and Essential because of the expected benefits for customers and shareholders. Equally as exciting is the commitment, made by both companies, to continued strong robust investment in our infrastructure that makes us among the top performers in safety and reliability in the nation while working to provide affordable service for all customers,” Franklin added.

“The regulatory approval processes for our merger with American Water continue to progress. Two weeks ago, we received our first approval of the merger from the Kentucky Public Service Commission. As a reminder, we have filed in all pertinent states. At the special shareholder meeting to approve the merger, approximately 95% of the voted shares were cast in favor of the transaction. This overwhelming mandate supports what we have believed from the start: that this combination creates a premier, multi-state utility with a high growth profile,” Franklin added.

First Quarter 2026 Operating Results

Essential reported GAAP net income of $224.4 million and earnings per share of $0.79 for the first quarter of 2026, compared to GAAP net income of $283.8 million and earnings per share of $1.03 for the same period in 2025. The first quarter of 2025 included the benefit of non-recurring items, including the release of an income tax reserve regulatory liability resulting from a rate order, proceeds from an insurance carrier reimbursing expenses related to a legal proceeding, and rate recovery of a regulated asset associated with bad debt.

Essential reported Q1 2026 non-GAAP EPS of $0.83, which reflects business results without the impact of merger-related expenses incurred in the quarter.

Revenues for the quarter were $861.8 million compared to $783.6 million in the first quarter of 2025, an increase of 10%. Additional revenues from regulatory recoveries and purchased gas costs were the main revenue drivers. Operations and maintenance expenses increased to $175.8 million for the first quarter of 2026, compared to $137.8 million in the first quarter of 2025, primarily due to increases in employee-related costs, including increases in overtime pay and outside service costs due to activities related to the cold weather in January and February, water production expenses, and merger-related expenses of $16.3 million.

Essential’s regulated water segment reported revenues for the quarter of $323 million, an increase of 7.4% compared to $300.8 million in the first quarter of 2025. Regulatory recoveries and increased volume were the largest contributors to the increase in revenues for the period. Operations and maintenance expenses for Essential’s regulated water segment increased to $103.1 million for the first quarter of 2026 compared to $89.4 million in the first quarter of 2025, driven by increased employee-related costs, increases in bad debt expense, and an increase in contractor services due to higher main break activity given the abnormal weather. Excluding the one-time items and the impact of abnormal weather, operations and maintenance expenses for the full year are expected to be in line with historic norms.

Essential’s regulated natural gas segment reported revenues for the quarter of $529.4 million, compared to $470.8 million in the first quarter of 2025, driven primarily by an increase in purchased gas costs, higher regulatory recoveries and an offset due to the weather normalization adjustment. Operations and maintenance expenses for Essential’s regulated natural gas segment increased slightly to $56.2 million for the first quarter of 2026 compared to $55.7 million in the first quarter of 2025.

Dividend

As previously announced on February 17, 2026, Essential’s board of directors declared a quarterly cash dividend of $0.3426 per share of common stock. This dividend will be payable on June 1, 2026, to shareholders of record on May 12, 2026.

Financing

On March 9, 2026, the Company issued $500 million of senior notes due March 15, 2036, with an interest rate of 5.125%. The Company used the net proceeds from the issuance to repay a portion of its commercial paper borrowings and for general corporate purposes.

As of March 31, 2026, Essential’s weighted average cost of fixed-rate long-term debt was 4.16%, and the company had $1.035 billion available on its credit lines.

Rate Activity

Thus far in 2026, the Company’s regulated water segment received rate awards or infrastructure surcharges that will increase annual revenues in Illinois, Indiana, Pennsylvania, and Ohio by $5.7 million, and its regulated natural gas segment received rate awards or infrastructure surcharges in Kentucky and Pennsylvania of $9.4 million.

The Company currently has base rate cases or infrastructure surcharges pending in Texas, Ohio, North Carolina, Virginia, and New Jersey for its regulated water and wastewater segment for an estimated $101.9 million in incremental annual revenues. The company currently has a base rate case pending in Pennsylvania for its natural gas segment with a requested revenue increase of $163.2 million to support its Long-Term Infrastructure Improvement Plan, which involves the replacement and retirement of aging gas mains and the associated reduction of greenhouse gas emissions.

Capital Expenditures

Essential invested approximately $269 million in the first three months of 2026 to improve its regulated water and natural gas infrastructure systems and to enhance customer service across its operations. The Company continues to be a leader in the United States at replacing miles of aged underground utility pipes and is committed to maintaining elevated levels of infrastructure investment. Essential is on track to invest $1.7 billion in needed infrastructure investments in 2026.

Water Utility Growth by Acquisition

Essential’s continued growth by acquisition allows the company to provide safe and reliable water and wastewater service to a larger customer base than it could from organic customer growth alone.

On March 4, 2026, Essential announced that it had closed on its $18 million purchase of the Greenville Municipal Water Authority in Mercer County, PA. The system serves more than 2,900 customers in Greenville Borough as well as Hempfield and West Salem Townships. The Pennsylvania Public Utility Commission (PUC) approved the transaction on January 15, 2026.

Since 2015, Essential has acquired approximately $570 million in rate base and added more than 138,000 new customers or equivalent dwelling units to the company’s footprint.

The company has signed purchase agreements for additional water and wastewater systems in Pennsylvania, Texas, North Carolina and New Jersey that are pending closing and are expected to serve over 201,000 customers or equivalent dwelling units and total approximately $285 million in purchase price. The Company’s $276.5 million agreement to acquire the Delaware County Regional Water Quality Control Authority (DELCORA), a Pennsylvania sewer authority that serves approximately 198,000 equivalent dwelling units in the Philadelphia suburbs, is included among these signed purchase agreements.

The pipeline of potential water and wastewater municipal acquisitions the Company is actively pursuing represents approximately 400,000 total customers.

Merger with American Water Works Company, Inc.

The Company is continuing to progress through the process of obtaining the consents and approvals needed to successfully consummate the proposed merger with American Water. On February 10, 2026, shareholders of both companies voted overwhelmingly in favor of merger-related proposals. In 2025, Essential submitted applications for required regulatory approval in all states where applicable. On April 20, 2026, we received an order from the Kentucky Public Utility Commission approving the merger. The merger remains on track for closing in the first quarter of 2027.

Financial and Growth Guidance

The Company’s latest expectations are the following:

• Anticipated growth in long-term earnings per share at a compound annual growth rate of 5% to 7% from the adjusted 2024 earnings per share of $1.97 (non-GAAP) for the three-year period through 2027.

• In 2026, regulated infrastructure investments are expected to be $1.7 billion.

• Multiyear plan to ensure that finished water does not exceed the federal maximum contaminant level of the six EPA-regulated PFAS chemicals.

Guidance Assumptions

Essential Utilities does not guarantee future results of any kind. Guidance is subject to risks and uncertainties, including, without limitation, those factors outlined in the “Forward Looking Statements” of this release and the “Risk Factors” section of the company’s annual and quarterly reports filed with the Securities and Exchange Commission. The earnings per share and infrastructure investment include the municipal water and wastewater acquisitions for which the company has entered into signed purchase agreements as of the date the guidance was announced, but do not include DELCORA or other potential acquisitions from the company’s list of acquisition opportunities that currently represents over 400,000 customer equivalents. While the company remains confident in its ability to close DELCORA, for guidance purposes, DELCORA has been removed from all guidance metrics. The company’s guidance includes the expectation that the company will continue to issue equity and debt on an as-needed basis to support acquisitions and capital investment plans.

Essential Utilities believes that the non-GAAP financial measure “adjusted earnings per share” used for 2024 and identified as part of its multi-year financial and growth guidance supplements investors the ability to measure the company’s financial operating performance for 2024, including by adjustment, as compared to the Company’s operating performance in 2024.

1Q 2026 Earnings Call Information

Date: May 7^th, 2026

Time: 11 a.m. EDT (please dial in by 10:45 a.m.)

Webcast and slide presentation link: https://www.essential.co/events-and-presentations/events-calendar

The call and presentation will be webcast live so interested parties may listen over the internet by logging on to Essential.co and following the link for Investors. The conference call will be archived in the Investor Relations section of the company’s website following the call.

About Essential

Essential Utilities, Inc. (NYSE: WTRG) delivers safe, clean, reliable services that improve quality of life for individuals, families, and entire communities. With a focus on water, wastewater, and natural gas, Essential is committed to sustainable growth, operational excellence, a superior customer experience, and premier employer status. We are advocates for the communities we serve and are dedicated stewards of natural lands, protecting thousands of acres of forests and other habitats throughout our footprint.

Operating as the Aqua and Peoples brands, Essential serves approximately 5.5 million people across nine states. Essential is one of the most significant publicly traded water, wastewater service and natural gas providers in the U.S. Learn more at www.essential.co.

Forward-Looking Statements

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which generally include words such as “believes,” “expects,” “intends,” “anticipates,” “estimates,” and similar expressions. The Company can give no assurance that any actual or future results or events discussed in these statements will be achieved. Any forward-looking statements represent its views only as of today and should not be relied upon as representing its views as of any subsequent date. Readers are cautioned that such forward-looking statements are subject to a variety of risks and uncertainties that could cause the company’s actual results to differ materially from the statements contained in this release. Such forward-looking statements include, among others: the anticipated receipt of regulatory approvals for, and closing of, the company’s proposed merger with American Water, the company’s belief that it will comply with the finalized EPA PFAS rules, the guidance range of net income per diluted common share; the anticipated amount of infrastructure investment in 2026; the Company’s anticipated use of equity and debt financing and, that the Company has a multiyear plan to ensure that finished water does not exceed the federal maximum contaminant level for the six EPA regulated PFAS chemicals. There are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements including: the expected timing and likelihood of completion of our proposed Merger with American Water; changes in the EPAs regulations; changes in the United States’ governmental policies, including those from the Executive Branch; disruptions in the global economy; potential disruptions in the supply chain for raw and finished materials; the continuation of the company’s growth-through-acquisition program; general economic business conditions; the company’s ability to successfully execute any equity or debt financing transactions, including on an as needed basis; housing and customer growth trends; unfavorable weather conditions; the success of certain cost-containment initiatives; changes in regulations or regulatory treatment; the company’s ability to successfully close municipally owned systems presently under agreement and successfully complete other acquisitions and dispositions; and other factors discussed in our Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q, which are filed with the Securities and Exchange Commission. For more information regarding risks and uncertainties associated with Essential’s business, please refer to Essential’s annual, quarterly, and other SEC filings. Essential is not under any obligation – and expressly disclaims any such obligation – to update or alter its forward-looking statements whether as a result of new information, future events, or otherwise.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260506294247/en/

Media Contact:

David Kralle

Vice President of Public Affairs

Media Hotline: 1.877.325.3477

[email protected]

Investor Contact:

Brian Dingerdissen

Vice President, Treasurer, FP&A, and IR

O: 610.645.1191

[email protected]

KEYWORDS: Pennsylvania United States North America

INDUSTRY KEYWORDS: Energy Natural Resources Utilities Other Natural Resources

MEDIA:

Logo

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

LOS ANGELES–(BUSINESS WIRE)–
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on May 5, 2026, the Compensation Committee of Puma’s Board of Directors approved the grant of inducement restricted stock unit awards covering 59,750 shares of Puma common stock to six new non-executive employees.

The awards were granted under Puma’s 2017 Employment Inducement Incentive Award Plan, which was adopted on April 27, 2017 and provides for the granting of equity awards to new employees of Puma. The restricted stock unit awards vest over a three-year period, with one-third of the shares underlying the award vesting on the first anniversary of the award’s vesting commencement date, May 1, 2026, and one-sixth of the shares underlying the award vesting on each six-month anniversary of the vesting commencement date thereafter, subject to continued service. The awards were granted as an inducement material to the new employees entering into employment with Puma, in accordance with Nasdaq Listing Rule 5635(c)(4).

About Puma Biotechnology

Puma Biotechnology, Inc. is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. Puma in-licensed the global development and commercialization rights to PB272 (neratinib, oral) in 2011. Neratinib, oral was approved by the U.S. Food and Drug Administration in 2017 for the extended adjuvant treatment of adult patients with early stage HER2-overexpressed/amplified breast cancer, following adjuvant trastuzumab-based therapy, and is marketed in the United States as NERLYNX® (neratinib) tablets. In February 2020, NERLYNX was also approved by the FDA in combination with capecitabine for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer who have received two or more prior anti-HER2-based regimens in the metastatic setting. NERLYNX was granted marketing authorization by the European Commission in 2018 for the extended adjuvant treatment of adult patients with early stage hormone receptor-positive HER2-overexpressed/amplified breast cancer and who are less than one year from completion of prior adjuvant trastuzumab-based therapy. NERLYNX® is a registered trademark of Puma Biotechnology, Inc.

In September 2022, Puma entered into an exclusive license agreement for the development and commercialization of the anti-cancer drug alisertib, a selective, small molecule, orally administered inhibitor of aurora kinase A. Initially, Puma intends to focus the development of alisertib on the treatment of small cell lung cancer and breast cancer. In February 2024, Puma initiated ALISCA™-Lung1, a Phase II clinical trial of alisertib monotherapy for the treatment of patients with extensive-stage small cell lung cancer. In November 2024, Puma initiated ALISCA™-Breast1, a Phase II clinical trial of alisertib in combination with endocrine therapy for the treatment of patients with HER2-negative, HR-positive metastatic breast cancer.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260506262009/en/

Alan H. Auerbach or Mariann Ohanesian, Puma Biotechnology, Inc., +1 424 248 6500

[email protected]

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Biotechnology Pharmaceutical Health Oncology

MEDIA:

Logo

General Mills Names Dana McNabb Chief Operating Officer

McNabb also joins Board of Directors

MINNEAPOLIS–(BUSINESS WIRE)–
General Mills (NYSE: GIS) today announced Dana McNabb has been promoted to Chief Operating Officer, effective June 1, 2026. McNabb will continue to report to Chairman and CEO Jeff Harmening and join General Mills’ board of directors.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260506479140/en/

McNabb has served as Group President of North America Retail since 2024 and added North America Pet to her responsibilities in 2025.

In addition to her current accountabilities leading North America Retail and North America Pet, McNabb will add responsibility for all General Mills’ operating segments and key operating functions, including the International and North America Foodservice segments and the Digital & Technology, Innovation, Technology & Quality, Strategy and Growth, and Supply Chain teams.

“Dana is a disciplined, strategic leader and results-driven operator with a proven passion for our brands and consumers,” said Harmening. “As someone who looks ahead and acts with urgency, Dana has led an initiative to reinvigorate our brands by strengthening their remarkability. She is exceptionally well suited to lead our global operations and restore profitable growth for General Mills and our shareholders.”

McNabb has served as Group President of North America Retail since 2024 and added North America Pet to her responsibilities in 2025. She previously held roles as Chief Strategy & Growth Officer; Group President, Europe & Australia segment; President of the U.S. Cereal operating unit; and Vice President of Global Marketing for Cereal Partners Worldwide (CPW), the company’s joint venture with Nestlé headquartered in Switzerland. McNabb started her General Mills career in Canada in 1999 and her marketing experience has spanned the company’s major businesses, including Cereal, Snacks, Meals and Dairy.

McNabb holds a bachelor’s degree in commerce from the University of Ottawa and a master’s degree in business administration from the London School of Business. She also serves on the board of directors of CPW.

About General Mills

General Mills makes food the world loves. The company is guided by its Accelerate strategy to boldly build its brands, relentlessly innovate, unleash its scale and stand for good. Its portfolio of beloved brands includes household names like Cheerios, Nature Valley, Blue Buffalo, Häagen-Dazs, Old El Paso, Pillsbury, Betty Crocker, Totino’s, Annie’s, Wanchai Ferry and more. General Mills generated fiscal 2025 net sales of U.S. $19 billion. In addition, the company’s share of non-consolidated joint venture net sales totaled U.S. $1 billion. For more information, visit www.generalmills.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260506479140/en/

Communications

[email protected]

763-764-6364

KEYWORDS: Minnesota United States North America Canada

INDUSTRY KEYWORDS: Supermarket Retail Convenience Store Food/Beverage

MEDIA:

Photo

McNabb has served as Group President of North America Retail since 2024 and added North America Pet to her responsibilities in 2025.

Logo